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ORIGINAL ARTICLE
Integrin α11β1 regulates cancer stromal stiffness and promotes
tumorigenicity and metastasis in non-small cell lung cancer
R Navab1, D Strumpf1, C To1, E Pasko1,2, KS Kim3, CJ Park1, J Hai1, J Liu1, J Jonkman1, M Barczyk4, B Bandarchi1, YH Wang1, K Venkat1,
E Ibrahimov1, N-A Pham1, C Ng1, N Radulovich1, C-Q Zhu1, M Pintilie1, D Wang1, A Lu1, I Jurisica1,5,6, GC Walker3, D Gullberg4 and
M-S Tsao1,2,6
Integrin α11β1 is a stromal cell-speciﬁc receptor for ﬁbrillar collagens and is overexpressed in carcinoma-associated ﬁbroblasts
(CAFs). We have investigated its direct role in cancer progression by generating severe combined immune deﬁcient (SCID) mice
deﬁcient in integrin α11 (α11) expression. The growth of A549 lung adenocarcinoma cells and two patient-derived non-small cell
lung carcinoma (NSCLC) xenografts in these α11 knockout (α11− /−) mice was signiﬁcantly impeded, as compared with wild-type
(α11+/+) SCID mice. Orthotopic implantation of a spontaneously metastatic NCI-H460SM cell line into the lungs of α11− /− and
α11+/+ mice showed signiﬁcant reduction in the metastatic potential of these cells in the α11− /− mice. We identiﬁed that collagen
cross-linking is associated with stromal α11 expression, and the loss of tumor stromal α11 expression was correlated with decreased
collagen reorganization and stiffness. This study shows the role of integrin α11β1, a receptor for ﬁbrillar collagen in differentiation
of ﬁbroblasts into CAFs. Furthermore, our data support an important role for α11 signaling pathway in CAFs, promoting tumor
growth and metastatic potential of NSCLC cells and being closely associated with collagen cross-linking and the organization and
stiffness of ﬁbrillar collagen matrices.
Oncogene (2016) 35, 1899–1908; doi:10.1038/onc.2015.254; published online 6 July 2015
INTRODUCTION
The biology of carcinomas is signiﬁcantly inﬂuenced by the tumor
microenvironment, which includes extracellular matrix, blood
vasculature, inﬂammatory cells and ﬁbroblasts.1–4 Recent studies
have shown the contribution of stromal ﬁbroblasts to cancer
initiation and progression,5–7 providing a rationale for develop-
ment of therapeutics against novel stromal targets.8,9
Integrins constitute a family of homologous transmembrane,
cell-matrix adhesion receptors expressed on all nucleated cells,
including tumor and tumor-associated host cells such as
endothelial cells and leukocytes, also present in the tumor
microenvironment.10,11 Leukocytes and endothelial cells express
multiple integrins including members of the β2 subfamily
(leukocytes) and members of the αv integrin subfamily (endothe-
lial cells).10,11 Integrins have not only been implicated as
mediators of tumor cell proliferation, migration and invasion,
but also as multifunctional receptors in the tumor stroma.11 They
are grouped into subfamilies on the basis of β-subunit associa-
tions, characteristics of the α subunit or the identity of partnering
ligands. All four collagen-binding integrins (α1, α2, α10 and α11)
heterodimerize with β1-subunit12,13 and bind native collagens
via their respective α I-domains, which recognize GFOGER
motifs.10,14–17 Collagen-binding integrins are involved in cell
adhesion, cell migration, remodelling of collagen lattices and
regulation of collagen turnover.18,19
In our previous study, using the representational difference
analysis technique, ITGA11 (integrin α11, α11) was among the top
six genes identiﬁed as differentially expressed in non-small cell
lung carcinoma (NSCLC) tumor stroma compared with the stroma
of normal lung.20 Furthermore, we conﬁrmed that α11 is
overexpressed in NSCLC-associated stromal ﬁbroblasts compared
with matched normal ﬁbroblasts.21,22 Our co-implantation studies
using NSCLC cells and SV40-immortalized mouse embryonic
ﬁbroblasts (MEFs) have demonstrated that α11 expression in
MEFs signiﬁcantly promotes tumorigenesis.21 These data provided
a rationale for exploring the effect of stromal integrin α11 on
tumor progression of lung cancer cells.
It is now well recognized that tumor initiation, growth, invasion
and metastasis result from a complex interplay between the host
microenvironment and the cancer cell.23 The biological role of the
tumor microenvironment in human lung cancer has not been
studied in depth. Here, we have studied the direct role of stromal
integrin α11 on the growth and metastasis of non-small cell lung
cancer cells using novel immune-compromised α11-deﬁcient
mice. Our results suggest that α11 is closely associated with
collagen cross-linking and stiffness within cancer stroma, thus
providing additional insights on stromal regulation of tumor
growth and metastasis in NSCLC.
RESULTS
Impact of stromal α11 deﬁciency on the growth of NSCLC cells
To generate the α11-deﬁcient mouse strain, a null mutation was
introduced into the mouse Itga11 gene by gene targeting.18 The
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α11-deﬁcient heterozygous C57BL/6J mice (+/− ) were originally
in a mixed C57BL/6 and 129 SvJ background. These mice have
been back-crossed at least 10 times to reach a homogenous
C57BL/6 background. Subsequently, they were bred with the
BALB/c severe combined immune deﬁcient (SCID) mice for seven
generations producing α11-deﬁcient heterozygous (+/− ) in a
SCID background (see Supplementary information, Supplementary
Figures S1a and d).
To evaluate the effect of stromal α11 on the growth of human
NSCLC cells, we implanted A549 lung adenocarcinoma cells into
the subcutaneous tissue of α11 wild-type (α11+/+), heterozygous
(α11+/− ) and homozygous-deleted (α11− /−) SCID mice. The
growth of the A549 cell line was impeded signiﬁcantly in
α11− /− compared with α11+/+ mice (Po0.00001) (Figure 1a and
Supplementary Figure S1e). This effect was also demonstrated
using cell lines derived from primary human lung adenocarcinoma
xenografts, PHLC 178 (Po0.0001; Figure 1b) and PHLC 655
(P= 0.05; Figure 1c).
It has been reported that collagen-binding integrin receptors
control the growth hormone/IGF-1-dependent biological activities
in mice with a combined deﬁciency of the α2β1 and α11β1
integrins, thus lacking the major receptors for collagen type I.24 To
exclude the possibility that the reduced growth rates are due to
this secondary pathway, we measured the circulating IGF-1 and
IGFBP-3 levels in the sera of α11− /− and α11+/+ mice when the
xenograft tumors reached the maximum size of 1.5 cm. The levels
of circulating IGF-1 and IGFBP-3 were similar in both groups of
mice (Supplementary Figures S1f and g).
To evaluate the lack of α11 in tumor stroma, immunohisto-
chemistry on frozen sections of the tumor xenografts conﬁrmed
the presence of mouse α11 in the tumor stroma of α11+/+ mice
(Supplementary Figures S2a and b) and the lack of mouse α11 in
the tumor stroma of α11− /− mice (Supplementary Figures
S2c and d). To characterize the tumor stroma in α11− /− mice,
serial sections of formalin-ﬁxed parafﬁn-embedded xenograft
tumors were stained with hematoxylin and eosin and PicroSirius
red and immunostained for cytokeratin (Supplementary Figure S3).
Using the PicroSirius red staining which stains all types of
collagen ﬁbers including ﬁbrillar collagens, we did not observe
any difference in collagen ﬁber staining in tumor stroma of
α11− / − xenograft tumors versus α11+/+. We used α-smooth
muscle actin (α-SMA) staining (Figure 1d) to quantify the relative
abundance (represented by pixels) of activated ﬁbroblasts in the
mouse tumor stroma in the three subcutaneous xenograft
tumors models using the Aperio ImageScope Version 11.2.0.780.
The pixel counts showed a decrease in α-SMA-positive pixels
in α11− / − xenograft tumors as compared with α11+/+ mice
(Supplementary Figure S4a).
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Figure 1. Tumorigenicity of NSCLC cells was impeded in SCID mice with a homozygous deleted α11 genotype and is related to differentiation
of ﬁbroblasts to myoﬁbroblasts (CAFs). (a) A total of 2 × 106 of either lung adenocarcinoma (A549) cells or primary adenocarcinoma lung
cancer cell lines PHLC 178 (b) and PHLC 655 (c) were implanted subcutaneously into the ﬂank of SCID mice with normal (+/+) and
homozygous (− /− ) deleted α11. Tumor growth was monitored and recorded every other 2 days. The data are represented as mean± s.e.m.
(n= 10). (d) Representative images of serial sections of formalin-ﬁxed parafﬁn-embedded xenograft tumors from three subcutaneous
xenograft tumors models were immunostained for α-SMA; scale bar, 100 μm. Images were taken at ×10 magniﬁcation. The top right corner of
each micrograph showing × 3 magniﬁcation of each image.
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A549-induced α11-associated tumor stromal gene expression
changes
We previously reported a set of differentially expressed genes that
were induced ⩾ four fold in tumors formed by co-implantation of
A549 cells with the SV40 immortalized α11+/+ compared with
α11− /− MEFs.21 We called this the exogenous stromal model.22
To identify potential mediators of tumor growth promotion
associated with integrin α11β1, we compared the global
gene expression proﬁles of A549 tumors formed in α11− /−
versus α11+/+ mice, and named it the endogenous stromal
model. In agreement with the immunostaining data, the expres-
sion levels of mouse Acta2 (α-SMA) was lower in xenograft tumors
formed in α11− /− compared with α11+/+ mice (Supplementary
Data Set S1a). In addition to observing this for A549 tumors,
reduced Acta2 levels in α11− /− mice was also conﬁrmed in
two additional PHLC tumor xenograft models (Figure 1d;
Supplementary Figure S4b). Furthermore, higher α-SMA protein
levels were observed in primary cancer associated ﬁbroblast (CAF)
cell lines compared with their matched normal ﬁbroblast (NF)
counterparts (Supplementary Figure S4c). This was further
investigated in hTERT (human Telomerase Reverse Transcriptase)
immortalized NF cell lines22 with different levels of ITGA11gene
expression (NF 094YFPhTERT, low α11 and NF 094YFPhTERT, high α11)
(see Supplementary Information; Supplementary Figure S4c),
which demonstrated a positive correlation between α11 levels
and α-SMA expression (Supplementary Figure S4c).
To identify the gene expression changes in A549 tumor cells
or in α11− /− and α11+/+ mouse tumor stroma, we proﬁled the
tumor-derived RNA using the Mouse WG-6v2 Illumina and
Human HT-12v4 Bead Chips (see Supplementary Informa-
tion; Supplementary Data Set S1a–d). We identiﬁed 342
(124 downregulated and 218 upregulated) mouse stromal genes
that were differentially expressed by at least 1.5-fold in the
A549 tumor stroma in α11− /− compared with α11+/+ mice
(Supplementary Data Set S1a and b; Supplementary Figure S5a).
Using the human chip, we identiﬁed 2687 (1271 downregulated
and 1416 upregulated) genes whose expression in cancer cells
was inﬂuenced by α11 expression in the tumor stromal ﬁbroblasts
(Supplementary Data Set S1c and d; Supplementary Figure S5b).
The expression changes of 8 mouse and 11 human genes were
validated using reverse-transcription qPCR (RT–qPCR) (Supplementary
Figures S5c and d).
Among the α11− /−-associated downregulated genes in stroma
of the A549 xenograft tumors was the collagen cross-linking
gene, lysyl oxidase-like 1 (Loxl1) (Supplementary Data Set S1a,
Figures 2a and b). Downregulation of LOXL1 expression was
further conﬁrmed in PHLC 655 and PHLC 178 tumor xenografts in
α11− /− versus α11+/+ mice (Figures 2c and d). To explore the
relevance of α11 and LOXL1 gene expression in the context of
NSCLC stroma versus normal lung, we used our published
microarray data using Affymetrix Exon 1.0 ST oligonucleotide
array on 15 laser-capture microscope tumor stroma and
α11
+/+
α11
-/-
_ _
______________p < 0.0001
A549/α11
-/-
A549/α11
+/+
P
oo
le
d 
# 
1
P
oo
le
d 
# 
2
P
oo
le
d 
# 
1
P
oo
le
d 
# 
2
________ ________
160 kDa
52 kDa
40 kDa
α11
LOXL1
GAPDH
CAF Tumor cells
0
5
10
15 p < 0.0001
R
e
la
ti
v
e
 m
R
N
A
 e
x
p
re
s
s
io
n
(f
o
ld
 c
h
a
n
g
e
)
0
0.5
1.0
1.5
2.0
L
O
X
L
1
 m
R
N
A
 e
x
p
re
s
s
io
n
 (
∆
C
t)
 
N
F 
09
4 
Y
FP
hT
E
R
T,
 L
ow
 α
11
N
F 
09
4 
Y
FP
hT
E
R
T,
 H
ig
h 
α1
1
LOXL1
α11
p = 0.0355
p = 0.0067
100 2 4 6 8
5
6
7 Normal lung
Tumor stroma
L
O
X
L
1
  
m
R
N
A
 e
x
p
re
s
s
io
n
α11 mRNA expression
0
0.5
1.0
1.5
160 kDa
52 kDa
40 kDa
α11
LOXL1
GAPDH
655/α11
-/-
655/α11
+/+
P
oo
le
d 
# 
1
P
oo
le
d 
# 
2
P
oo
le
d 
# 
1
P
oo
le
d 
# 
2
________ ________
α11
LOXL1
GAPDH
-/- +/+
________ ________178/α11 178/α11
P
oo
le
d 
# 
1
P
oo
le
d 
# 
2
P
oo
le
d 
# 
1
P
oo
le
d 
# 
2
160 kDa
52 kDa
40 kDaR
e
la
ti
v
e
 L
O
X
L
1
m
R
N
A
 e
x
p
re
s
s
io
n
Figure 2. Correlation between ITGA11 and LOXL1 gene expression. (a) RT–qPCR for LOXL1 gene expression in A549 xenograft tumors in α11− /−
compared with α11+/+ mice. (b and c) Western blot analysis showing absence of mouse α11 and decrease of LOXL1 proteins in A549 (b), PHLC
655 (c) and PHLC 178 (d) tumor xenografts from α11− /− compared with α11+/+ mice (eight tumor xenografts were pooled into two groups).
(e) Correlation between LOXL1 and α11 gene expression from microarray data using Affymetrix Exon 1.0 ST oligonucleotide array on 15 laser-
capture microscope (LCM) tumor stroma and corresponding normal lung tissue from 15 NSCLC primary tumors (Spearman r= 0.7925;
P valueo0.0001). (f) RT–qPCR representing a comparison of LOXL1 gene expression in 20 CAFs and 41 lung cancer tumor cell lines. ΔCt
indicates higher values correspond to lower gene expression levels. (g) RT–qPCR results show a signiﬁcant correlation between LOXL1 and α11
gene expression in NF 094YFPhTERT, low α11 and NF 094YFPhTERT, high α11 cell lines.
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corresponding normal lung tissue from the same 15 NSCLCs that
were used to establish CAFs and NFs.22 There was a signiﬁcant
correlation between the LOXL1 and α11 gene expression in NSCLC
stroma versus normal lung (Spearman r= 0.7925; P valueo0.0001)
(Figure 2e). Using RT–qPCR, we surveyed the expression of LOXL1
in a panel of 20 human lung cancer-derived CAF and 41 NSCLC
cell lines. We observed relatively low LOXL1 levels across all NSCLC
cell lines (Figure 2f). The correlation between LOXL1 and α11 gene
expression was also observed in NF 094YFPhTERT, low α11 and
NF 094YFPhTERT, high α11 cell lines22 (see Supplementary Information;
Figure 2g).
Protein–protein interaction (PPI) network reveals genes/proteins
regulated by α11
The Gene Set Enrichment Analysis for the downregulated genes
on the mouse-speciﬁc microarray for A549 xenografts in α11− /−
versus α11+/+ SCID mice indicated a signiﬁcant enrichment in
genes annotated to the Biocarta integrin signaling pathway (see
Supplementary Information).
A PPI network of potential direct PPIs between the down-
regulated genes and integrin-mediated signaling pathway genes
revealed a PPI between the focal adhesion kinase/protein tyrosine
kinase 2 (FAK/PTK2) and genes/proteins belonging to the integrin-
mediated pathway (Supplementary Figure S6).25 Western blot
analysis showed reduced phosphorylation of FAK and the
extracellular signal-regulated kinase (Erk) proteins in A549
xenografts from integrin α11− /− versus α11+/+ mice (Figures 3a
and c). Additional putative associations of downregulated genes
with proteins of the integrin-mediated signaling pathway were
observed in the PPI networks, suggesting a broad involvement for
genes regulated by integrin α11 (Supplementary Figure S6).
Matrisome components contribute to tumor and stromal cell
cross-talk
We hypothesized that the putative functions of the differential
downregulated gene expression changes in human epithelial
tumor and mouse stroma may reﬂect on tumor–stroma interac-
tions via extracellular/secreted proteins. We therefore focused on
the human and mouse downregulated matrisomal genes (glyco-
proteins, collagens, proteoglycans, extracellular matrix (ECM)
afﬁliated, ECM regulators and secreted factors; see Supplementary
Information; Figure 4). Further PPI analysis revealed networks
between several of the downregulated genes and ﬁbrillar collagens
(for example, biglycan, bone morphogenetic protein1; Figure 4, light
blue shading). Importantly, the analysis points to potential associa-
tions of downregulated genes with growth factors in pathways
previously implicated in CAF differentiation and tumorigenesis
(Figure 4, yellow shading) including latent transforming growth
factor beta binding protein 3 (LTBP3) and latent transforming growth
factor beta binding protein 4 (LTBP4) association with transforming
growth factor beta 1 (TGFB1), transforming growth factor beta 2
(TGFB2) (TGFβ signaling); WNT1 inducible signaling pathway protein
2 (WISP2), insulin-like growth factor binding protein 2 (IGFBP2),
insulin-like growth factor binding protein 4 (IGFBP4) association with
insulin-like growth factor 1 (IGF1) and insulin-like growth factor 2
(IGF2) (IGF signaling); syndecan 4 (SDC4) association with ﬁbroblast
growth factor 2 (FGF2) (FGF signaling); semaphorin 3 F (Sema3f) and
glypican 1 (Gpc1) with vascular endothelial growth factor A (VEGFA)
(VEGF signaling); ﬁbulin 1 (FBLN1) and latent transforming growth
factor beta binding protein 3 (Ltbp3) with heparin-binding EGF-like
growth factor (HBEGF) (signaling via heparan sulfate proteoglycans
and EGFR). Taken together, the potential association of matrisomal
deregulated genes in key pathways provides additional insight into
how ITGA11 may affect CAF differentiation and tumorigenesis. This is
in accordance with the observed phenotypes showing reduced
tumor growth and defects in CAF differentiation in A549
xenografts in integrin α11− /− versus integrin α11+/+ mice.
α11 promotes ﬁbrillar collagen reorganization and tissue stiffness
We next examined whether integrin α11 has a role in collagen
stiffness in tumor xenografts. Microscopic analysis of parafﬁn
sections of α11− /− and α11+/+ tumor xenografts revealed the
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Figure 3. Lack of α11 in NSCLC xenograft tumors showed a decrease in FAK and protein tyrosine kinase 2 (PTK2) activity. (a) Western blot
analysis was performed on eight tumor xenografts from α11− /− and α11+/+ mice (pooled into two groups) to detect phosphorylation levels of
intermediate molecules involved in the integrin signaling pathway such as FAK and PTK2. (b and c) Densitometry was used to quantify the
phosphorylation levels using the Image J analysis software (http://imagej.nih.gov/ij/index.html).
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progressive non-linearization of the collagen adjacent to the
tumor cells in α11− /− as compared with α11+/+ mice (Figure 5a, top
and middle panels). Furthermore, Second Harmonic Generation
(SHG) imaging which illuminates almost exclusively ﬁbrillar collagen2
conﬁrmed the lack of collagen organization in tumor xenografts
formed in α11− /− versus α11+/+ mice (Figure 5a, bottom panels and
Supplementary Figure S7a, top and bottom panels). The total
amount of ﬁbrillar collagen was signiﬁcantly reduced in A549, PHLC
178 and PHLC 655 xenografts in α11− /− versus α11+/+ mice
(Supplementary Figure S7b). Quantitative analysis of collagen ﬁber
orientation in tumor xenografts from α11− /− versus α11+/+ mice
showed a signiﬁcant correlation between collagen ﬁber arrangement
and α11 expression (Supplementary Figure S7c).
Height images obtained from atomic force microscopy (AFM)
(Figure 5b) revealed dispersed holes on the surface of α11− /−
samples, indicative of the lack of collagen organization. Moreover,
AFM elasticity measurements (Figures 5c and d) showed
signiﬁcantly higher modulus values in tumor xenografts formed
in α11+/+ versus α11− /− mice, presumably due to greater
reorganization activity of collagen ﬁbrils by integrin α11β1-
expressing cells.
α11 promotes the metastatic potential of NCI-H460SM cells
To evaluate whether integrin α11 has a role in promoting the
metastatic potential of NSCLC cells, we performed orthotopic
implantation of NCI-H460SM lung carcinoma cells in integrin
α11− /−, α11+/− and α11+/+ mice (see Supplementary Information).
The H460SM cell line was previously established for its ability to
metastasize spontaneously when implanted into the lungs of
nude rats.25 H460SM cells formed primary tumor growth equally
well in all groups: α11+/+ (16/16), α11+/− (9/9) and α11− /− (13/14)
mice. While systemic metastasis to bone, kidney and brain were
found in all α11+/+ (16/16) mice, signiﬁcant reduction was noted in
α11+/− (1/9) and α11− /− (3/14) mice, suggesting contribution of
stromal α11 expression to lung cancer metastasis (Table 1).
DISCUSSION
We have demonstrated directly using an in vivo α11 endogenous
model in SCID mice that stromal α11 expression affects the
tumorigenicity and metastatic potential of NSCLC cells. Further-
more, we showed that the expression of collagen cross-linking
gene, LOXL1, is associated with stromal α11 expression, and that
Figure 4. The putative functional effect of transcriptional downregulation of matrisomal genes on the tumor microenvironment. Human and
mouse differentially downregulated genes (DDG) annotated as matrisomal proteins were matched to PPI in I2D and the resulting PPI network
was visualized in NAViGaTOR (see Supplementary Information). A subset of PPI from this network, shown here, containing 38 human
matrisomal DDG and 13 mouse matrisomal DDG, represents potential direct PPI between human matrisomal DDG (black PPI/edges), or with
mouse matrisomal DDG (thick grey edges), PPI via other matrisomal proteins or with plasma membrane proteins (thin grey edges), and with β
integrin proteins (blue edges). PPI of downregulated genes with growth factors or with ﬁbrillar collagens are highlighted by yellow and light
blue shading, respectively. Node/protein color indicates matrisome annotation categories or β integrin. Additional annotation of proteins is
also indicted by a colored rim around each node: Red—Gene Ontology GO:0005583 ﬁbrillar collagen; Brown—Plasma membrane protein
(brown); Green—Genes differentially downregulated on both human and mouse microarrays. Node shape indicates deregulation as indicted
in the legend. Gene Name is provided with human and mouse naming convention. The cellular context may apply to the tumor cells (human),
stroma cells (mouse) or both, and is based on the annotation of individual proteins as matrisomal proteins and/or plasma membrane proteins.
Asterisk in the gene name indicates a protein for which secreted and membrane-bound isoforms are described. Some nodes and edges were
faded-out from the original PPI network to reduce the complexity of this network/image.
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loss of tumor stromal α11 expression was correlated with
decreased collagen stiffness. These results suggest a role for α11
in promoting NSCLC tumor progression by affecting the collagen
stiffness of the tumor stroma.
Fibroblasts express the α1β1, α2β1 and α11β1 collagen-binding
integrins.26 Of these, only α2β1 and α11β1 bind to and remodel
the ﬁbrillar form of collagen I present in collagen gels.
Experimental data also suggest that collagen-binding ECM
molecules, named COLINBRIS, with time are deposited in the
collagen lattices, and binding of other integrins like αvβ3 integrins
to these bridging molecules also can mediate contraction of the
collagen lattices.27
The integrin α11 chain in vivo displays a remarkable restricted
expression in the human and mouse embryos, being restricted to
subsets of ﬁbroblasts.28,29 In the developing dermis, α11 expres-
sion is restricted to ﬁbroblasts and no expression has been
detected in other stromal cell types, such as vascular cells,
immune cells or hematopoietic cell types. Furthermore, the
ﬁbroblast-restricted expression has been conﬁrmed in transgenic
reporter mice where 3 kb of the human ITGA11 promoter was able
to drive a ﬁbroblast-restricted expression.30 The dermal ﬁbro-
blast-restricted expression of α11 in adult dermis has been
conﬁrmed in two independent studies.31,32 The tumor stroma formed
in α11-deﬁcient mice showed decreased Acta2 (which encodes for
α-SMA) expression. Data from other systems suggest that α11β1 is
involved in myoﬁbroblast differentiation.33,34 Because stiffness is
a driving factor for myoﬁbroblast differentiation, it is possible
that reduced α11-dependent collagen organization and collagen
cross-linking are contributing factors to lower SMA levels.
Recently, it was shown that less granualtion tissue and less
α-SMA-positive myoﬁbroblasts formed in wounds from α11− / −
mice.35 Our data suggest that α11 may regulate the differentia-
tion and expression of α-SMA also in CAFs.
Our previous co-implantation studies using NSCLC cells and
SV40-immortalized MEFs showed that α11 expression in MEFs
signiﬁcantly promotes tumorigenicity (exogenous stromal
model).21 However, the result was tempered by the SV40-
immortalized MEF themselves being weakly tumorigenic. To
directly conﬁrm the tumor-promoting effect of stromal integrin
α11, we have evaluated the growth of tumor cells in α11− /−
compared with their syngeneic wild-type α11+/+ SCID mice
(endogenous stromal model). We observed signiﬁcantly reduced
tumor growth of NSCLC cell lines in α11− /− as compared with
α11+/+ mice, thus strengthening the evidence for α11 being an
important stromal factor in tumorigenicity of NSCLC cells.
The mouse downregulated genes were annotated to the
Biocarta integrin-mediated signaling pathway. To validate this
pathway, western blot analysis showed reduced levels of activated
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Figure 5. Collagen cross-linking accompanies lung cancer tumorigenesis. (a) Representatives are photomicrographs of A549 tumor xenograft
sections. Photomicrographs of collagen ﬁbers from tumor xenograft sections stained with PicroSirius red and viewed under parallel
(top panel) and polarized light (middle panel) on wideﬁeld microscope (BX51, Olympus); scale bar, 25 μm. The bottom panel shows two-
photon confocal SHG images of the tumor xenograft sections; scale bar, 100 μm. (b–d) Representative images of tissue samples and
quantiﬁcation of their stiffness distribution by AFM indicating the absence of α11 alters extracellular matrix organization in lung cancer
xenograft model. (b) Height and deﬂection images collected from Digital Instrument Dimension 5000 AFM in contact mode; scale bar 1 μm.
(c and d) Representing histograms of Young’s modulus of A549/α11+/+ (c) and A549/α11− /− (d) xenograft tumors determined by AFM.
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FAK and ERK1/2 in A549 tumor cell lysates from α11− /− compared
with α11+/+ mice. A role of FAK in macrophage and ﬁbroblast
migration is well established.36–38 Therefore, it is possible that the
endogenous stromal model proceeds in a step-wise manner
where the ﬁbroblasts ﬁrst proliferate, migrate, and then make
contact with tumor cells. The tumor cells then respond to this
contact by secreting growth factors such as transforming growth
factor beta (TGF-β) that activate stromal ﬁbroblasts to CAF.7 It has
been shown that human mammary ﬁbroblasts are converted into
CAFs during the course of tumor progression in a breast tumor
xenograft model.39 This effect occurs because of autocrine
activating signaling loops, mediated by TGF-β and stromal
cell-derived factor-1 (SDF-1) cytokines.39 Consistent with this,
ITGA11 promoter analysis has identiﬁed functional Smad-binding
elements in the promoter.30 Furthermore, we previously reported
that ITGA11 together with six other CAFs/tumor stroma genes act
as transcriptional targets of the TGF-β signaling pathway.22
As the tumorigenic role of α11 appears speciﬁc among the
interstitial collagen-binding integrins, it is important to identify
genes, especially ones encoding for other extracellular or secreted
proteins that could be speciﬁcally regulated by integrin α11β1.
Among potential α11-regulated mouse genes, we demonstrated
that the expression of Loxl1, was downregulated in xenograft
tumors formed in α11− /− as compared with α11+/+ mice. LOX
family oxidases (LOX and LOXL 1–4) are collagen cross-linking
enzymes40 that inﬂuence tumor progression41 and metastasis.42
However, the role of LOXL1 in lung adenocarcinoma is not known.
A recent study suggested that LOX in ﬁbrotic lungs regulate
myoﬁbrobalst differentiation at the inﬂammatory phase.43 In our
human microarray data, we observed that the expression
of TGFβRII is upregulated in A549 xenograft tumors in integrin
α11− /− as compared with α11+/+ mice, while in our mouse
microarray data, the expression of Loxl1 is downregulated in A549
xenograft tumors in integrin α11− /− as compared with α11+/+
mice. Intriguingly, downregulation of TGFβRII expression in
conjunction with upregulation of lysyl oxidase (LOX), a gene
homologous to LOXL1, has been associated with poorer patient
prognosis in lung adenocarcinoma.41 The reduced TGFβRII
expression in NSCLC has been associated with a more aggressive
tumor behavior characterized by increased cell migration and
increased TGF-β1 synthesis, the latter suggested to attract
immune cells.44
To evaluate possible interactions between the gene products in
human tumor and mouse stromal cells, we applied human and
mouse downregulated matrisomal genes in PPI networks. Our
analysis suggest a link between extracellular (ﬁbrillar collagens)
and secreted (growth factors) proteins in tumor–stroma inter-
actions. Collectively, the potential functional association of
matrisomal deregulated genes in key pathways provides additional
insight into how integrin α11 may affect CAF differentiation and
tumorigenesis.
Reduced tumorigenicity in α11− /− as compared with α11+/+
mice was accompanied by disorganized collagen at the tumor
cell/stroma interface. In tumor xenografts propagated in α11− /−
mice, total ﬁbrillar collagen decreased as compared with α11+/+
mice. In addition, SHG imaging of tumor xenografts revealed the
lack of reorganization of the ﬁbrillar collagen adjacent to the
developing epithelial lesions in α11− /− as compared with α11+/+
mice. Previous studies have suggested that reduced collagen
cross-linking leads to repressed tumor progression.2 Moreover,
collagen cross-linking in lung ECM promotes breast tumor
metastasis,45 demonstrating that ECM organization and stiffness
is a key regulator of tumor progression. In the current study, the
strong association of α11 with collagen stiffness supports an
interesting link between cancer cell and the induction of a
supportive stroma, which favors cancer cell invasion and
migration. CAFs appear to exert a direct physical impact on tumor
tissues,46 resulting in increased ECM stiffness around tumor cells
and consequently mechanical stress. Here, we have also demon-
strated that integrin α11 has a pivotal role in the metastatic
potential of NSCLC cells. The incidence of systemic metastasis to
bone, brain, kidneys, lymph nodes and left lung was signiﬁcantly
lower in α11+/− and α11− /− compared with α11+/+ (12/16) mice.
In summary, we have shown that stromal α11 expressed by
CAFs has a signiﬁcant effect on tumor growth and metastasis of
NSCLC cells, and this appears to be associated with changes in the
expression of genes involved in collagen cross-linking and
collagen stiffness. Targeting α11 represents a potentially novel
approach to treat NSCLC, especially in an adjuvant setting.
MATERIALS AND METHODS
Methods for PPI of mouse differentially expressed genes and networks are
provided in detail in Supplementary Information.
Animals and cell lines
SCID mice were bred on-site and obtained from the Princess Margaret
Cancer Centre (Toronto, ON, Canada) Animal Resource Center. All
manipulations were done under sterile conditions in a laminar ﬂow hood
in accordance with protocols approved by the Institutional Animal Care
Committee at the University Health Network (UHN). The general health of
the animals was assessed daily. For more information on development of
α11-deﬁcient and immune-deﬁcient mice, please refer to Supplementary
Experimental Procedures.
NCI-H460SM, A549 and primary human lung cancer cells (PHLC 178 and
PHLC 655) were cultured at 37 °C in RPMI 1640 media containing 10% fetal
bovine serum. To culture primary human lung cancer cells, fragments of
human lung tumors grown in SCID mice were processed into a single cell
suspension to establish PHLC 178 and PHLC 655 cell lines.47 Tumor
fragments were minced and then digested with collagenase at 37 °C for 1 h.
Table 1. Effect of Integrin α11 on tumor growth and metastasis of H460SM in mice
Experimental arms Tumor take Regional mets (No. of animals) Systemic mets (No. of animals) No. of animals with systemic mets
LN L. lung Bone Kidney Brain Yes No
α11+/+ (n= 16) 16 16 12 8 6 6 12 4
α11+/− (n= 9) 9 7 4 0 1 0 1 8
α11− /− (n= 14) 13 4 5 2 1 0 3 11
Abbreviations: L. lung, left lung; LN, lymph node; mets, metastasis. Incidence of systemic metastasis in orthotopic model using α11 SCID mice. The metastatic
potential of H460SM cells was demonstrated by endobronchially implanting 1.0 × 106 cells into the right caudal lobe of α11− /−, α11+/− and α11+/+ SCID mice.
Metastatic occurrences were assessed macroscopically and microscopically. Any visible tumor deposit other than the primary tumor was considered as
metastasis. Primary tumor weight and the weight of the mediastinal lymph node were measured to evaluate tumor burden. The H460SM cells produced
statistically signiﬁcant systemic metastases (12/16) to brain, kidney, L. lung or bone in the α11+/+ animals when compared with α11+/− or α11− /− SCID mice
(Po0.0152). Fisher’s exact test was used for comparison of the incidence of metastasis.
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Next, cells were treated with DNase at 37 °C for 10min and re-suspended in
RPMI 1640 media with 10% fetal bovine serum to end the dissociation.
Magnetic columns (MACS Technology, Santa Barbara, CA, USA) coated with
H2Kb/H2Dd anti-mouse antibodies were used to isolate human cells from
mouse ﬁbroblast cells in the cell population.
Subcutaneous tumorigenicity assay
α11 SCID mice were bred on-site at the Ontario Cancer Institute animal
facility. All manipulations were done under sterile conditions in a laminar
ﬂow hood, in accordance with protocols approved by the UHN Animal
Care Committee. Tumor cells (2 × 106) were implanted subcutaneously into
the abdominal ﬂank of 6-week-old male α11+/+ and α11− /− SCID mice.
Tumor growth was assessed as previously described.48
Orthotopic model to evaluate metastatic potential of α11
Three groups of SCID mice, α11+/+ (n= 16), α11+/− (n=10) and α11− /−
(n=15) were assigned for orthotopic implantation of H460SM cells. Animal
deaths occurring less than 21 days post implantation were considered to
be due to surgical-related complications and were excluded from the ﬁnal
comparative analysis. When any animal from any group succumbed to the
disease or demonstrated terminal sign and symptoms, a single animal
from each of the other groups was killed. This allows a direct comparison
of all groups at the same time point for tumor metastatic potential. Survival
was not an end point of the study.
The procedure for endobronchial tumor cell implantation in rodent was
previously reported in detail.25 Mice were anesthetized by intraperitoneal
injection of Ketamine (80mg/kg) and Xylazine (10mg/kg). Cultured cells
were harvested by trypsinization and adjusted to a ﬁnal concentration
of 1 × 106 cells/20 μl for endobronchial implantation using a 24-gauge,
0.75-inch-long Teﬂon catheter. The catheter was passed into the distal
bronchus of right caudal lobe through a small tracheotomy incision. The
cell suspension was injected. After withdrawal of the catheter, the
tracheotomy was repaired with a 6-0 Proline suture (Ethicon, Inc,
Sommerville, NJ, USA), and the incision was closed with sterile wound
clips. The mice were returned to their cages on sterile rolled drapes to
maintain their semi-upright position. The animals were given antibiotics
Baytril (Bayer, Mississauga, ON, Canada) in water for 1 week post-
operatively. The assessment of metastatic potential is described in
Supplementary Materials and Methods.
Reverse transcriptase-quantitative polymerase chain reaction
(RT–qPCR) assay
Total RNA was extracted from CAF, NSCLC tumor cell lines and two pooled
samples of xenograft tumors arisen in α11− /− and α11+/+ SCID mice. Each
pool consisted of four tumors. Following this, total RNA (2 μg) was
reverse-transcribed using Superscript II reverse transcriptase (Invitrogen,
Burlington, ON, Canada). A 10 ng equivalent of complementary DNA was
used for each quantitative PCR assay performed with the Stratagene
Mx3000p Sequence detection System using SYBR green 2x master mix
(Stratagene, La Jolla, CA, USA). To verify the lack of α11 mRNA in α11− /−
SCID mice, RT–qPCR was carried out using RNA from the tail tissue and
primers corresponding to the exon 2 and 3 of mouse Itga11 sequence:
Forward 5′-tcacggacaccttcaatatggatac-3′ and Reverse 5′-gaa tctgaagt
tggagttgacccgt-3′. Human- and mouse-speciﬁc primers were used to
detect the gene expression of ITGA11 and LOXL1: human ITGA11 (forward
5′- gatgggctcatcgacctg-3′ and reverse 5′-acagaatcacagcgttgcc-3′). Human
LOXL1 (forward 5′-gtcgctacgtttctgcaaca-3′ and reverse 5′- gctttggaag
gggagagatt-3′) and mouse Loxl1 (forward 5′- ggcctcagggagtgaacat -3′ and
reverse 5′- caatcttgctgtgtgggatg -3′).
To validate the microarray studies, 11 up- and downregulated human
genes and 8 downregulated mouse genes in A549 xenograft tumors in
α11− /− versus α11+/+ SCID mice were selected in the correlation analysis.
Genes that had higher fold change were selected: human genes
(up: HNRNPK, TXNRPD1, CNBP, SPP1, RNASE4, EEF1A1. down: EHD2, CRYAB,
HSPA1B, TMEM132A, HSPA1A) (for primers list, please refer to
Supplementary Table S1a) and mouse genes (down: Wisp2, Loxl1, Gpc1,
Igfbp4, Bgn, Ltbp3, Grn, Plod3) (for primers list, please refer to
Supplementary Table S1b) were tested in the correlation analysis.
Predicted PCR product sequences were veriﬁed using BLAST for
recognition of target and non-target sequences. Dissociation curves were
performed as routine veriﬁcation to check the primers for ampliﬁcation of
a single band, and template dilution standard curves (5 log range) were
conducted with each primer set to verify a linear relationship between
template concentration and Ct values (R240.9).
Western blot analysis
To extract total protein, two pooled samples of eight xenograft tumors in
α11+/+ and α11− /− mice were homogenized in lysis buffer (1% Triton
X-100, 10% glycerol, 50mM Hepes, 150 mM NaCl, 1.5 mM MgCl2, 10mM
sodium pyrophosphate, 100mM NaF, 10 mM Na4P2O4, 1 mM EDTA, 10mg/
ml aprotinin, 10 mg/ml leupeptin,100 mg/ml PMSF and 1mM sodium
orthovanadate), and the lysates were cleared by centrifugation. Protein
samples were fractionated on sodium dodecyl sulfate/polyacrylamide gels
and transferred to polyvinylideneﬂuoride membranes. The membranes
were blocked with 5% non-fat dry milk and incubated with primary
antibodies to human α11,49 FAKpY397, FAKpY925, total FAK, MAPK pY44/42,
total MAPK, SrcpY416, total Src, Akts473, total Akt (Cell Signaling, Danvers,
MA, USA) and LOXL1 (Santa Cruz, Dallas, TX, USA) at 1:1000 dilution.
Visualization used horseradish peroxidase-linked anti-rabbit and anti-
mouse secondary antibodies (Cell Signaling) and ECL-Plus blotting
substrate detection kit (GE Healthcare Life Sciences, Mississauga, ON,
Canada).
Immunostaining and imaging
Cryosections (5 microns thick) of xenograft tumors were ﬁxed in cold
acetone for 5 min, rehydrated in phosphate-buffered saline and blocked
using 10% bovine serum albumin. Following phosphate-buffered saline
rinses, the slides were incubated with a primary antibody, rabbit
polyclonal-anti integrin α11 afﬁnity-puriﬁed antibody at the dilution of
1:500 and a mixture of mouse monoclonal cytokeratin antibodies
(AE1/AE3, Dako, Burlington, ON, Canada) composed of an equal mixture
of AE1/AE3 at the dilution of 1:200 for 1 h at 37 °C. Following phosphate-
buffered saline/Tween 0.05% washes, the cryosections were incubated
for 1 h at room temperature with Cy5-conjugated goat anti-rabbit IgG
(1:100 dilution; Jackson Immunology Laboratory, Bar Harbor, MA, USA) and
Cy3-conjugated goat anti-mouse IgG (1:800 dilution; Jackson Laboratory)
secondary antibodies. The slides were mounted in Vectashield mounting
medium (Vector Laboratories, Burlingame, CA, USA) for ﬂuorescence
microscopy.
Fibrillar collagen was visualized in 5-μm-thick parafﬁn sections of
xenograft tumors using 0.1% PicroSirius Red staining. Sections were
imaged with polarized-light microscopy using parallel and perpendicular
polarizer orientations on an Olympus (Richmond Hill, ON, Canada) BX51
microscope.
Serial sections (5 μm thick) from formalin-ﬁxed parafﬁn-embedded
blocks of xenograft tumors were stained for hematoxylin and eosin and
PicroSirius red staining using PicroSirius red stain kit (Polysciences,
Warrington, PA, USA). These histological sections were also immunostained
for rabbit polyclonal anti-cytokeratin (PanCK, 1:3000, Dako) and mouse
monoclonal anti-α-SMA (1:400, Dako).
SHG imaging and quantitation of collagen organization
SHG imaging is a powerful method of illuminating collagen ﬁbrils in tissue
irrespective of their orientation.50–52 Unstained ﬁxed and deparafﬁnized
tissue sections were mounted and visualised under a Zeiss (Toronto, ON,
Canada) LSM510 NLO multi-photon microscope, equipped with a
femtosecond laser (Coherent Chameleon) tuned to 840 nm. The SHG
signal is collected at exactly one-half of the illumination wavelength (that
is, 420 nm) using a narrow bandpass ﬁlter. Confocal detection is not
required owing to the two-photon illumination, so the detector pinhole
was opened wide to collect the most signal. Autoﬂuorescence is generated
in the tissue at the same time, so this was collected in a separate detection
channel using a 450–600 nm bandpass ﬁlter. The percentage of the
autoﬂuorescence image (typically about 20%) was subtracted from the
SHG image to obtain a pure SHG image, representing only ﬁbrillar collagen.
The background-corrected SHG images were analyzed using a novel
relative linearity index that we have developed based on established
texture analysis53 available as a plugin for the freeware Image J analysis
software (http://imagej.nih.gov/ij/index.html). The grey-level co-occurrence
matrix Texture Analysis plugin in Image J was used to evaluate the
correlation of pixels in a given direction, which is a measure of linearity in
that direction. Rotating the SHG images in 15 degree increments through
180 degrees gives the linearity as a function of direction. The difference
between the maximum and minimum linearity values through the rotation
gives a robust measure of whether collagen ﬁbrils are organized randomly
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or whether they have a preferred direction: a relatively high number
indicates more linear structures in the image and a relatively low number
indicates random orientation of the collagen ﬁbrils.
Atomic force microscopy
Parafﬁn blocks of A549/α11+/+ and A549/α11− / − xenograft tumors were
cut into 10-μm-thick sections. Prior to the AFM measurement, each
section was immunostained with hematoxylin and eosin to deﬁne the
stroma-rich regions. The samples were maintained in phosphate-
buffered saline during the AFM session. Three xenograft tumor sections
from each group (A549/α11+/+ and A549/α11− / −) were used for AFM
quantiﬁcation of Young’s elastic modulus of the cancer-associated
stroma. AFM indentations were performed using an MFP-3D AFM
(Asylum Research, Santa Barbara, CA, USA). Silicon nitride cantilevers
(Bruker, Goleta, CA, USA) with a nominal spring constant of 0.06 N/m
were used. Accurate spring constant was determined using thermal
noise method before each measurement.54 Samples were indented at a
1 μm/s loading rate, ramp size of 5 μm and with a maximum force of
500 pN. The Young’s modulus was determined by considering load-
indentation dependence for a paraboloidal tip shape. The determination
of the elastic modulus of the tissue (E1) from force-distance curves was
performed using the Hertz model (Equation 1).55,56
F ¼ 4
ffiffiffi
R
p
3 1 - v2ð ÞEδ
3=2 ð1Þ
Where F is the loading force (N), E is the Young’s modulus (Pa), v is the
Poisson ratio, R is the radius of curvature of the tip (m) and δ is the
indentation depth (m). Tissue samples were assumed to be incompres-
sible and a Poisson’s ratio of 0.5 was used in the calculation of the
Young’s elastic modulus.
Statistical analysis
Differences in tumor growth rates of xenografts were tested using mixed
effect model estimation.57 Chi-Square and Fisher exact test were used for
metastatic experiments and t test for qRT–PCR assays.
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